3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pancreatic Neoplasms
18
Prostatic Neoplasms
10
Liver Neoplasms
7
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Unresectable Pancreatic Cancer
2
Stomach Neoplasms
2
Neoplasms
2
Lymphatic Metastasis
2
Locally Advanced Pancreatic Cancer
2
Kidney Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Adenocarcinoma Resectable
1
Pancreatic Adenocarcinoma Locally Advanced
1
Melanoma
1
Liver, Cancer of, Non-Resectable
1
Liver Metastasis Colon Cancer
1
Interventions
Cisplatin
25
Cetuximab
12
Radiotherapy
11
Docetaxel
11
Fluorouracil
9
Carboplatin
9
Surgical Procedures, Operative
8
Radiotherapy, Intensity-Modulated
8
pembrolizumab
7
Magnetic Resonance Spectroscopy
7
Radiation
6
Surveys and Questionnaires
5
Specimen Handling
5
Drug Therapy
5
toripalimab
4
Standard of Care
4
Celecoxib
4
1,2-diaminocyclohexaneplatinum II citrate
4
X-Rays
3
Platinum
3
Paclitaxel
3
Nutritional Status
3
Interviews as Topic
3
Hydroxyurea
3
Counseling
3
Biopsy
3
130-nm albumin-bound paclitaxel
3
Taxes
2
Resistance Training
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Laryngeal Neoplasms
×
Electroporation
×
Clear all
NCT02430675
2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA
Completed
30 enrolled